We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc (TMO)

Closed February 29 04:00PM
After Hours: 06:50PM


StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
545.0023.3030.9010.2727.100.000.00 %03-
547.5020.8028.3019.5224.550.623.28 %482/28/2024
550.0018.3025.4015.4921.850.000.00 %013-
552.5015.9023.3015.0219.606.0266.89 %492/28/2024
555.0014.1020.8011.3017.450.000.00 %09-
557.5013.7018.507.0016.100.000.00 %02-
560.0011.4015.1012.7013.254.8561.78 %2122/28/2024
562.509.8012.607.7611.200.000.00 %03-
565.007.909.309.408.602.9946.65 %19182/28/2024
567.506.507.006.776.752.7769.25 %282/28/2024
570.004.905.404.605.151.0529.58 %36262/28/2024
575.002.402.802.612.600.9658.18 %29502/28/2024
580.001.001.650.951.3250.033.26 %1,4581,4392/28/2024
585.000.350.650.450.500.1550.00 %10932/28/2024
590.000.100.400.210.25-0.06-22.22 %9102/28/2024
595. %172/28/2024
600. %00-
605.000.150.850.150.500.000.00 %01-
610.000.001.350. %00-
615.000.001.500. %00-


StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
545.000.050.400.500.2250.000.00 %067-
547.500. %08-
550.000.050.300.450.175-1.07-70.39 %3412/28/2024
552.500.050.300.210.175-0.79-79.00 %982/28/2024
555.000.100.350.300.225-1.65-84.62 %472292/28/2024
557.500.250.450.500.35-1.71-77.38 %39132/28/2024
560.000.400.651.000.525-2.39-70.50 %1032/28/2024
562.500.701.100.940.90-2.61-73.52 %42202/28/2024
565.001.101.402.801.25-2.40-46.15 %63152/28/2024
567.501.702.051.851.875-4.95-72.79 %10252/28/2024
570.002.552.953.502.75-4.60-56.79 %5102/28/2024
575.005.005.500. %00-
580.008.209.300.008.750.000.00 %00-
585.0011.9015.400.0013.650.000.00 %00-
590.0014.5022.000.0018.250.000.00 %00-
595.0019.5027.000.0023.250.000.00 %00-
600.0023.4032.100.0027.750.000.00 %00-
605.0031.2037.000.0034.100.000.00 %00-
610.0033.4043.000.0038.200.000.00 %00-
615.0039.4046.900.0043.150.000.00 %00-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
VANIVivani Medical Inc
$ 3.6305
VTVTvTv Therapeutics Inc
$ 16.848
ADILAdial Pharmaceuticals Inc
$ 1.60
COCHEnvoy Medical Inc
$ 2.21
BETSBit Brother Ltd
$ 4.18
CRGECharge Enterprises Inc
$ 0.0253
IASIntergral Ad Science Holding Corporation
$ 10.02
SMXSMX Security Matters Public Company
$ 0.2183
INGNInogen Inc
$ 6.29
PRSTPresto Technologies Inc
$ 0.3975
MARAMarathon Digital Holdings Inc
$ 31.00
VANIVivani Medical Inc
$ 3.6305
NKLANikola Corporation
$ 0.7684
SOUNSoundHound AI Inc
$ 6.3201
GOEVCanoo Inc
$ 0.10675

TMO Discussion

View Posts
InvestingIdeas InvestingIdeas 9 months ago
Thermo Fisher Scientific Inc Shares
Since the announcement of the idea, investors have already received a pre-tax return of 328% or an average annual return of 21.67%. Is it possible to expect such returns in the future? Based on today’s calculations, over a five to six-year perspective, one can expect an average annual stock price growth of 10%-17%. With dividends, the return may be slightly higher.
Jstocks44 Jstocks44 1 year ago
Great company. Stable and growing.
Jstocks44 Jstocks44 1 year ago
Great company. Stable and growing.
BOS BOS 3 years ago
Looks ready to go back to $540 range
Street Smart Street Smart 3 years ago
this will keep edging higher and higher
trades2win trades2win 3 years ago
Loading up zone on the 500 calls here this stock is way over sold
LivinLarge8 LivinLarge8 3 years ago
Load up INO with this one huge

$INO Thermo Fisher $TMO a $160 billion corporation has partnered with Inovio to manufacture up to 100 million doses of INO-4800 in 2021 and perhaps even more in 2022 and beyon
spotonge spotonge 4 years ago
Nice buy at the right time!
BoilerRoom BoilerRoom 4 years ago
$TMO took starter here yesterday.
Investorr Investorr 5 years ago
Great news today! $PRED is going to be a beast. Uplist to Nasdaq next week!

PRED: Thermo Fisher Scientific and Predictive Laboratories Announce Global Infertility Research Collaboration
north40000 north40000 5 years ago
ValueInvestor15 ValueInvestor15 7 years ago
5yr DCF analyses implies Thermo Fisher $TMO is 20% undervalued... earnings Tuesday:

DCF Analysis
Nickw Nickw 11 years ago
Good insightful read again from Goldman Sachs 34th Annual Global Healthcare Conference...
Penny Roger$ Penny Roger$ 12 years ago
~ $TMO ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $TMO ~ Earnings expected on Wednesday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.

~ Barchart:
~ OTC Markets:
~ Google Finance:
~ Google Fin Options: h
~ Yahoo! Finance ~ Stats:
~ Yahoo! Finance ~ Profile:
~ BusyStock:
~ CandlestickChart:
~ Investorshub Trades:
~ Investorshub Board Search:
~ Investorshub PostStream Search:
~ Investorshub Goodies Search:
~ Investorshub Message Search:
~ MarketWatch:
~ E-Zone Chart:
~ 5-Min Wind:
~ 10-Min Wind:
~ 30-Min Wind:
~ 60-Min Wind:

*If the earnings date is in error please ignore error. I do my best.
Pro-Life Pro-Life 13 years ago
3 straight weeks of nothing but ugly...
Pro-Life Pro-Life 13 years ago
For the week: +0.06%
Pro-Life Pro-Life 13 years ago
-0.11% is the scorecard for the week... great Friday close!!!
Pro-Life Pro-Life 13 years ago
Deeply oversold here...
GrandeS GrandeS 13 years ago
Nice FDA approval. Look for strong steady increase in TMO. Also watch for ALRT. They expect their first FDA approval soon. Now only .09, should go to $1.00 or above upon approval.
Pro-Life Pro-Life 13 years ago
My friends, for the week: -1%
Pro-Life Pro-Life 13 years ago
Thermo Fisher Scientific to Acquire Dionex Corporation
Date : 12/13/2010 @ 7:00AM
Source : Business Wire
Stock : Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Dionex Corporation (NASDAQ: DNEX), a leading manufacturer and marketer of chromatography systems, today announced that their Boards of Directors have unanimously approved a transaction under which Thermo Fisher will acquire all of the outstanding shares of Dionex for $118.50 per share in cash, or a total purchase price of approximately $2.1 billion. The transaction is not conditioned on financing and is expected to be completed in the first quarter of 2011.

Under the terms of the agreement, Thermo Fisher will commence a tender offer to acquire all of the outstanding shares of Dionex common stock for $118.50 per share in cash. The consideration represents a 21% premium to Dionex’s closing stock price on December 10, 2010, the last trading day prior to today’s announcement and a 32% premium to Dionex’s average closing stock price over the last 60 trading days. Thermo Fisher expects to realize total operating synergies of $60 million in year three following the transaction’s close through a combination of cost savings and revenue enhancements. The transaction is expected to be immediately accretive to Thermo Fisher’s adjusted earnings per share by $0.13 to $0.15 in the first 12 months following the close. Adjusted earnings per share and adjusted operating income are non-GAAP measures that exclude certain items detailed later in this press release under the heading “Use of Non-GAAP Financial Measures.”

Dionex, based in Sunnyvale, Calif., introduced the first ion chromatography system for water analysis shortly after its founding in 1975 and has consistently grown through innovation and global expansion. Today, the company has more than 1,600 employees in 21 countries spanning six continents, including a significant presence in the Asia-Pacific region. Dionex will be integrated into Thermo Fisher’s Analytical Technologies Segment.

“We believe the combination of Thermo Fisher and Dionex is extremely compelling from a technology, market and financial perspective,” said Marc N. Casper, president and chief executive officer of Thermo Fisher. “Dionex’s strength in chromatography instruments, software and consumables complements our leading positions in mass spectrometry and laboratory information management systems. The transaction, which we expect to be immediately accretive, is consistent with our strategy of accelerating growth by increasing our depth of capabilities to serve attractive end markets. Specifically, it complements our strong presence in China, where we’ve established the headquarters for our global environmental instruments business and continue to build our commercial infrastructure to meet the needs of customers in growing water quality, consumer safety and life sciences markets.”

“We are pleased to be joining Thermo Fisher and are excited about the opportunities we will have as part of the world leader in serving science,” said Frank Witney, president and chief executive officer of Dionex. “Thermo Fisher’s commitment to innovation will fuel our ongoing technology development, and their global manufacturing and commercial presence will significantly strengthen our ability to deliver quality products and services to our customers around the world. This transaction offers immediate and significant value for our shareholders, as well as the opportunity for our customers and employees to benefit from combining two highly complementary organizations. We look forward to working closely with the Thermo Fisher team to ensure a smooth transition and complete the transaction as expeditiously as possible.”

Mr. Casper continued, “We are delighted to welcome Dionex’s talented and dedicated employees to our team. Together, we will offer our customers new solutions based on a powerful combination of leading instruments, software, consumables and services.”

Benefits of the Transaction

- Creates a Leading Chromatography Offering: The transaction brings two complementary chromatography portfolios together to create the most extensive chromatography instruments, software and consumables offering in the industry. Specifically, it combines Dionex’s ion and liquid chromatography systems and consumables with Thermo Fisher’s gas chromatography systems and consumables.

- Improves Performance and Productivity: Customers will benefit from the combination of Thermo Fisher’s leadership in mass spectrometry with Dionex’s comprehensive chromatography offering. By integrating these leading technologies and related software, Thermo Fisher will be able to deliver exceptional performance and productivity for customers through improved sample analysis and data management.

- Strengthens Software Growth Platform: Dionex’s gold standard chromatography data system coupled with Thermo Fisher’s leading enterprise laboratory information management systems creates the most comprehensive desktop and enterprise software capabilities in the industry. This combination will significantly improve performance, productivity and compliance for customers to maximize their return on investment.

- Expands Presence in Applied Markets: Thermo Fisher will benefit from Dionex’s significant customer base and relationships in attractive applied markets, including environmental analysis, food safety and other industrial sectors. Through this combination, Thermo Fisher will be able to deliver unmatched analytical solutions for a growing range of testing needs, particularly water analysis, where growth is driven by new regulatory requirements and increased testing in developing countries such as China.

- Increases Footprint in Asia-Pacific: Dionex currently generates more than 35% of its revenues in Asia-Pacific and other emerging high-growth geographies. The company has a history of growth in the region by establishing a strong reputation through its well-regarded direct sales and service presence there. This transaction is consistent with Thermo Fisher’s strategy of investing to increase its footprint in Asian markets, such as China and India, as well as other strategic growth markets, like Brazil.

- Offers Significant Synergies: The transaction is expected to generate a total of approximately $60 million of cost and revenue synergies in year three after the transaction’s close. This includes approximately $40 million from cost-related synergies and $20 million of adjusted operating income benefit from revenue-related synergies.

Mr. Casper concluded, “The acquisition of Dionex is another example of the great progress we’re making in executing on our strategy to accelerate growth. We have invested in technology innovation, Asia expansion and complementary acquisitions – all to strengthen our growth opportunities in attractive end markets. We are focused on these strategic investments because they create value for all our key stakeholders – customers, employees and shareholders.”

Financing and Approvals

Thermo Fisher intends to use cash on hand and proceeds from committed financing from Barclays Capital and J.P. Morgan Securities LLC to facilitate the transaction. The transaction, which is expected to be completed in the first quarter of 2011, is subject to the satisfaction of customary closing conditions, including applicable regulatory approvals.


Barclays Capital and J.P. Morgan Securities LLC are acting as financial advisors to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel. Goldman, Sachs & Co. is acting as financial advisor to Dionex, and Cooley LLP is serving as legal counsel.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use the non-GAAP financial measures adjusted operating income and adjusted earnings per share. Adjusted operating income excludes restructuring and other costs/income and amortization of acquisition-related intangible assets. Adjusted earnings per share also excludes certain other gains and losses, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events and discontinued operations. We exclude the above items because they are outside of our normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. We believe that the use of non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecasts the company's performance, especially when comparing such results to previous periods or forecasts.

Conference Call and Webcast

Thermo Fisher and Dionex will host a conference call and Webcast at 8:30 a.m. EST today to provide more information on this announcement. The Webcast and accompanying slides can be accessed at and An audio archive of the call will be available on both companies’ Websites until December 27, 2010, at 11:59 pm EST.

Conference Call Dial-in: Domestic: (866) 610-1072

International: (973) 935-2840

Passcode: 31400437

Replay Dial-in: Domestic: (800) 642-1687

International: (706) 645-9291

Passcode: 31400437

Pro-Life Pro-Life 13 years ago
Since the wicked drop this summer, nothing but up!
Pro-Life Pro-Life 14 years ago
And there was no follow through at all... as the market goes, so goes this stock.
Pro-Life Pro-Life 14 years ago
Nice reversal in place on the daily...
Pro-Life Pro-Life 14 years ago
60 days later, they caved but a nice reversal candle today...
Pro-Life Pro-Life 14 years ago
The long term averages are acting as support...
Pro-Life Pro-Life 14 years ago
Correcting/consolidating... we are watching.
Pro-Life Pro-Life 14 years ago
Still going like the energizer bunny!
Pro-Life Pro-Life 14 years ago
The weekly continues to reflect the strong intact uptrend.
Pro-Life Pro-Life 14 years ago
Consolidating the last 2 months or so.
Pro-Life Pro-Life 15 years ago
What a ride since the 20 buck low in November '08...
Pro-Life Pro-Life 15 years ago
Moving back up after a little correction...
Pro-Life Pro-Life 15 years ago
Capitulation took place and the march is on apparently...
Pro-Life Pro-Life 15 years ago
The chart appears to be rolling over to the downside...
Pro-Life Pro-Life 15 years ago
The MACD has issued a sell... the uptrend still seems to be in place...
Pro-Life Pro-Life 15 years ago
That buy signal given at Thanksgiving seems to be in full effect right now...
Built2Trade Built2Trade 15 years ago
day trade this!!!!
Pro-Life Pro-Life 15 years ago
Lately, what a beat down... maybe a good buying op???
Pro-Life Pro-Life 16 years ago
Board name needs to be changed ASAP -

ThermoFisher Scientific (NYSE) TMO
Pro-Life Pro-Life 16 years ago
No posts here for over a year... i-Box needs TLC... maybe I can help.
Pro-Life Pro-Life 16 years ago
8K just released:
Pro-Life Pro-Life 16 years ago
News just released:

Thermo Fisher Scientific Acquires FIBERLite Centrifuge, Inc.
Acquisition Reinforces Thermo Fisher's Extensive Portfolio of Laboratory Centrifuge Rotors

WALTHAM, Mass.--(BUSINESS WIRE)--July 25, 2008--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has acquired FIBERLite Centrifuge, Inc., of Santa Clara, California. FIBERLite is the world's foremost supplier of carbon fiber centrifuge rotors, a strong and lightweight alternative that provides customers with a number of advantages over traditional metal rotors, including performance, safety, productivity and durability.

* The novelist George Eliot once said that "it is never too late to become what you might have been." That quote inspires me to seek those investments in the future that I didn't in the past.

Pro-Life Pro-Life 16 years ago
Quietly, this company is growing -
trythisagain trythisagain 17 years ago

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |